Cited by 978BRCA gene mutations in cancerGenetic factors in colorectal cancerPARP inhibition in cancer therapy

The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.

BRCA1 and BRCA2: 1994 and beyond

Narod, Steven A., Foulkes, William D.·2004·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

The discovery of the first gene associated with hereditary breast cancer, BRCA1, was anticipated to greatly increase our understanding of both hereditary and sporadic forms of breast cancer, and to lead to therapeutic and preventive breakthroughs. Much has been learned during the past decade about the genetic epidemiology of breast cancer, the ethnic distribution and clinical consequences of BRCA1 and BRCA2 mutations, and the central role of DNA repair in breast cancer susceptibility. The ability to translate this knowledge into novel treatments, however, remains elusive.

Integrity signals

Registry

Crossref · 10.1038/nrc1431

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Self-citation
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citation
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Self-citation
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., & Sekiya, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2766 · Cited by 3,589
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
Struewing, J., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,399

Flagged first, then by citations

Show all 187 references

Sorted by citations

Items 901–978 of 978

Breast Cancer Risk-reducing Strategies in BRCA1/2 Mutation Carriers
Heemskerk‐Gerritsen, B. A. M. (2014) · EUR Research Repository (Erasmus University Rotterdam)
Biomarkers in Breast Carcinomas
Sahin, Y., Erdoğdu, İ. H., Durak, M. G., Gürel, D., & Şahin, A. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-84432-5_11
BRCA1 Variant Assessment Using a Simple Analytic Assay
Kim, D. M., Feilotter, H. E., & Davey, S. K. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab163
Ovarian Cancer
Rittiluechai, K., Ji, Y., Lounsbury, K. M., Howe, A. K., & Verschraegen, C. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-21683-6_18
Managing DNA Strand Breaks in Eukaryotic Cells
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. (2014) · ASM Press eBooks · doi:10.1128/9781555816704.ch18
Predictive role of Ubiquitin-conjugating enzyme E2T in recurrence-free survival and aromatase inhibitor responsiveness in breast cancerPreprint
Zhang, W., wang, S., Zhang, R., Qu, S., Lyu, J., Lyu, R., & Wang, N. (2022) · Research Square · doi:10.21203/rs.3.rs-1389609/v1
Interrelationship of the Fanconi Anemia/BRCA Pathway
McChesney, P. A., & Kupfer, G. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-69147-3_5
Feature
(2009) · Asia-Pacific Biotech News · doi:10.1142/s0219030309000160
Drugs That Target
PhD, E. V. (2018) · Wiley eBooks · doi:10.1002/9781119126843.ch4
Faculty Opinions recommendation of BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.
Pellegrini, L. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731736629.793537569
BRCA Mutation
Hardy, A. N., Tarasewicz, E., & Jeruss, J. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5891-3_3
Functional roles of EMP-associated targets in breast cancer models
Toh, A. K. L. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.207818
Faculty Opinions recommendation of BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.
Tainer, J. A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731736629.793545761
Cancer Genes and Breast Cancers
Budak, M., & Seğmen, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104801
BRCA1 and BRCA2 germline mutation analysis from a cohort of 1,267 high-risk breast cancer patients in BrazilPreprint
Villela, D., Mazzonetto, P. C., Milanezi, F., Andrea, M., Martins, S., Monfredini, P. M., Silva, J. D. S., Perrone, E., Schnabel, B., Nakano, V., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1942605/v1
Colorectal cancer with germline BRCA1 variant: A case reportPreprint
Kim, K. M., Lee, M. R., Ahn, A. R., & Chung, M. J. (2022) · Research Square · doi:10.21203/rs.3.rs-2367890/v1
Future on a Flashdrive: Timely Considerations for the Imminent Adoption of Whole Genome Sequencing in Pediatric Healthcare
Hohmann, E., King, B., Laroche, R. A. S., Wilkinson, A., & Wilkinson, A. F. (2023) · Journal of Science Policy & Governance · doi:10.38126/jspg210305
Immunogenetics of Cancer
Díaz‐Peña, R., Mondelo‐Macía, P., & Castro, P. G. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_46-1
A comprehensive survey on spectrum of BRCA1 and BRCA2 pathogenic variants in breast and ovarian cancer
Elbiad, O., Laraqui, A., Ennaji, M. M., Badaoui, B., & Ennibi, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85496-2.00007-5
Data from Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from BRCA Mutation Carriers Resemble High-Grade Serous Carcinoma
Tone, A. A., Begley, H., Sharma, M., Murphy, J., Rosen, B. P., Brown, T. J., & Shaw, P. (2023) · doi:10.1158/1078-0432.c.6516894
Supplementary Methods 1 from Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer
Cecchini, M., Zhang, J. Y., Wei, W., Sklar, J., Lacy, J., Zhong, M., Kong, Y., Zhao, H., DiPalermo, J., Devine, L., et al. (2023) · doi:10.1158/2767-9764.23593088
Supplementary Methods 1 from Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer
Cecchini, M., Zhang, J. Y., Wei, W., Sklar, J., Lacy, J., Zhong, M., Kong, Y., Zhao, H., DiPalermo, J., Devine, L., et al. (2023) · doi:10.1158/2767-9764.23593088.v1
Mechanisms of Oncogenesis
Guleria, K., & Sambyal, V. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_9-1
Interpretation of Missense Variants Found in Association with Cancer
Chiaraluce, R., & Consalvi, V. (2023) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0029460
What can we learn from tumors? Parallels in cell and human behavior
Šmardová, J. (2023) · Masarykova univerzita eBooks · doi:10.5817/cz.muni.m280-0377-2023
A Postpartum Breast Cancer Diagnosis Reduces Survival in Germline BRCA pathogenic variant CarriersPreprint
Zhang, Z., Ye, S., Bernhardt, S. M., Nelson, H. D., Velie, E. M., Borges, V. F., Woodward, E. R., Evans, D. G., & Schedin, P. S. (2023) · medRxiv · doi:10.1101/2023.12.21.23300040
Evaluation of the BRCA2 Gene Variants Association with the Risk of Breast Cancer in the Iranian Population
Hosseinzadeh, M. T., Nematpour, F. S., & Afshar, A. S. (2024) · Jentashapir Journal of Cellular and Molecular Biology · doi:10.5812/jjcmb-148337
Mechanisms of Oncogenesis
Guleria, K., & Sambyal, V. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_9
BRCA1/2 germline sequencing in children and adolescents with cancer: it is the context that matters
Goudie, C. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae339
Green Tea's EGCG: Brewing Hope in the Battle against Breast Cancer
Kumar, M., Lal, R., Sehgal, A. K., Rawat, S., Kumar, A., Kumar, S., & Dhatwalia, S. K. (2025) · The Natural Products Journal · doi:10.2174/0122103155349614241215045420
Genetic behind breast cancer: Germline and somatic factors
Sharma, R., Sharma, R. K., Khodke, P., Tiwari, J. K., Garg, V. K., Okpala, C. O. R., Buttar, H. S., Thakur, S., Goel, N., & Kashyap, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24838-2.00005-7
Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Cancer: Systematic Review and Network Meta-AnalysisPreprint
Xiao, G., Yan, J., Cai, Z., Wu, M., Zhang, R., Yang, X., Yao, Y., Xiong, Z., Ye, M., Zhang, J., et al. (2025) · medRxiv · doi:10.1101/2025.03.11.25323491
Bilateral oophorectomy and the probability of amnestic mild cognitive impairment among carriers of a pathogenic variant in BRCA1 or BRCA2
Ji, C., Kim, S. J., Kim, R. H., Bordeleau, L. J., Foulkes, W. D., Panchal, S., Cohen, S. A., Sun, S. B., McKetton, L., Troyer, A. K., et al. (2025) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2025.101929
Self-citation
Journey of Breast Cancer from Pyramid Age to Molecular Era
Baruah, A., & Das, S. (2025) · Journal of Applied Biochemistry & Laboratory Medicine · doi:10.5005/jablm-11031-0009
Tandem duplication and triplication in BRCA1: revisiting the large genomic rearrangements via optical genome mapping
Allister, A. B., Lühmann, J. L., Wendeburg, L., Dechend, F., Beger, C., Tölle, S., von Ehr, J., Ripperger, T., Auber, B., Donato, N. D., et al. (2025) · Cancer Genetics · doi:10.1016/j.cancergen.2025.07.002
Immunogenetics of Cancer
Díaz‐Peña, R., Mondelo‐Macía, P., & Castro, P. G. (2025) · Springer eBooks · doi:10.1007/978-3-032-00749-0_46
Repair for Estrogen-Induced DNA Damage Requires BRCA1
Yamazaki, K., Takayasu, K., Masai, H., & Sasanuma, H. (2025) · Springer eBooks · doi:10.1007/978-981-96-6779-6_3
The role of breast cancer gene 1 and breast cancer gene 2 in determining breast cancer therapy
Sosse, S. A., & Ennaji, M. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30225-1.00037-3
A Novel ATRIP Mutation Detected in an Iranian Family with Familial Clustering of Breast Cancer: A Case Report
Zamani, N., Chahal, M., Salahshourifar, I., Talebian, R., & Akbari, M. R. (2025) · Current Oncology · doi:10.3390/curroncol32120711
Genome-scale DNA methylation analyses of cancer in children
Wong, N. C., & Ashley, D. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777271.030
Stromal Modulation of Radiation Carcinogenesis in Breast Cancer
Nguyen, D. H. H. (2011) · eScholarship (California Digital Library)
Cap a un model complet de la xarxa molecular alterada en l’anèmia de Fanconi i el càncer de mama
Sànchez, G. M. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Gen-Werden – Gen-Wandel?
Palfner, S. (2010) · VS Verlag für Sozialwissenschaften eBooks · doi:10.1007/978-3-531-92526-4_3
Additional file 5 of Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health
Andaluz, S., Zhao, B., Sinha, S., Lagniton, P. N. P., Costa, D. A., Ding, X., Brito, M., & Wang, S. M. (2024) · Figshare · doi:10.6084/m9.figshare.26713364
Additional file 2 of Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health
Andaluz, S., Zhao, B., Sinha, S., Lagniton, P. N. P., Costa, D. A., Ding, X., Brito, M., & Wang, S. M. (2024) · Figshare · doi:10.6084/m9.figshare.26713355
Additional file 1 of Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health
Andaluz, S., Zhao, B., Sinha, S., Lagniton, P. N. P., Costa, D. A., Ding, X., Brito, M., & Wang, S. M. (2024) · Figshare · doi:10.6084/m9.figshare.26713352
Additional file 1 of Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study
Kang, E. K., Jung, J.-J., Lim, C., Kim, H.-K., Lee, H.-B., Han, W., & Moon, H.-G. (2024) · Figshare · doi:10.6084/m9.figshare.25045417
Additional file 1 of Influence of cellular models and individual factor in the biological response to chest CT scan exams
Devic, C., Bodgi, L., Sonzogni, L., Pilleul, F., Ribot, H., Charry, C. D., Moigne, F. L., Paul, D., Carbillet, F., Munier, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19382490
Additional file 6 of Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health
Andaluz, S., Zhao, B., Sinha, S., Lagniton, P. N. P., Costa, D. A., Ding, X., Brito, M., & Wang, S. M. (2024) · Figshare · doi:10.6084/m9.figshare.26713367
Additional file 3 of Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health
Andaluz, S., Zhao, B., Sinha, S., Lagniton, P. N. P., Costa, D. A., Ding, X., Brito, M., & Wang, S. M. (2024) · Figshare · doi:10.6084/m9.figshare.26713358
Additional file 1 of RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination
Wu, X.-T., Wang, Y.-H., Cai, X.-Y., Dong, Y., Cui, Q., Zhou, Y.-N., Yang, X.-W., Lu, W.-F., & Zhang, M. (2021) · Figshare · doi:10.6084/m9.figshare.13663182
Additional file 4 of Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health
Andaluz, S., Zhao, B., Sinha, S., Lagniton, P. N. P., Costa, D. A., Ding, X., Brito, M., & Wang, S. M. (2024) · Figshare · doi:10.6084/m9.figshare.26713361
Depletion of BRCA1 Potentiates Progestin-Induced Cytoskeletal Changes in an Ovarian Cancer Cell ModelPreprint
Baquier, J., Gillis, N. E., Diep, C. H., Mauro, L. J., & Lange, C. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.02.697409
Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis
Lee, L., Tachibana, Y., Matsuo, S., Niina, Y., Fujiyama, T., Hisano, T., Sugimoto, R., Akashi, T., Ogoshi, K., & Furukawa, M. (2026) · JCO Precision Oncology · doi:10.1200/po-25-01104
Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1
Communal, L. (2011) · theses.fr (ABES) · doi:10.70675/7a7d9515ze600z463czbc06z794a9a77b7ae
Recombinaison homologue protège contre les défauts de la mitose et la ségrégation des chromosomes déséquilibre causé par le stress de réplication spontanée
Wilhelm, T. (2011) · theses.fr (ABES) · doi:10.70675/8f8f5907z32edz4a84zb3c8zc042507f5b0d
Prédispositions génétiques au cancer du sein et de l'ovaire dans la population suisse entre 1996 et 2009 : bilan de l'activité oncogénétique et du dépistage de mutations constitutionnelles dans les gènes BRCA1/BRCA2
Ayme, A. (2013) · theses.fr (ABES) · doi:10.70675/9e63b493z9591z4b85zb3d5zb41ad5fbfe7a
Vasoactive intestinal peptide (VIP) controls the development of the nervous system and its functions through VPAC1 receptor signalling : lessons from microcephaly and hyperalgesia in VIP-deficient mice
Maduna, T. (2017) · theses.fr (ABES) · doi:10.70675/85862ecezc818z440dz947cz5e99ac908090
Rôle des déterminants génétiques constitutionnels dans le cancer du sein
Curtit, E. (2017) · theses.fr (ABES) · doi:10.70675/8daa3e5fz8315z427cz8450zdfeb505b2b30
Cibler l'homéostasie du cholestérol cellulaire pour traiter le cancer du sein
Hassen, C. B. (2019) · theses.fr (ABES) · doi:10.70675/6d6b691bzf471z4a63za9e9z60d94fb98d0a
Reprogrammation comportementale : modèles, algorithmes et application aux maladies complexes
Biane, C. (2018) · theses.fr (ABES) · doi:10.70675/2c367370z3ea6z46cez997czc25478fd2287
Characterization of the functional interaction between BRCA2 and PARP1 in maintaining genome stability
Dumoulin, I. (2022) · theses.fr (ABES) · doi:10.70675/5a518b74z365dz46f8za66dz86c3a615bafb
Shedding light on the mechanisms of tumor formation linked to BRCA2 using two known pathogenic variants
Minello, A. (2023) · theses.fr (ABES) · doi:10.70675/a617053fz0e2dz45d2z9937zf00d8c266a6a
Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase) Inhibitors: A Single-Institution Experience
Akkoc-Mustafayev, F. N., Fountzilas, E., Munsell, M. F., Layman, R. M., Yam, C., Gutierrez‐Barrera, A. M., Albarracin, C. T., Ahmed, Z., Schlacher, K., Tainer, J. A., et al. (2026) · Cancers · doi:10.3390/cancers18081258
Identification of Influential Node Group in Attributed Graph through Explaining Graph Neural Network
Tan, X. J., Su, T., Wu, J., Zhang, Y., Xu, B., Shen, D., Wang, M., & Wang, B. (2026) · International World Wide Web Conference (WWW) · doi:10.1145/3774904.3792471
Comprehensive BRCA1/2 mutation landscape in prostate cancer in the UAE and Arab population
Shareef, Z. A., Al-Shahrabi, R. M., Bhamidimarri, P. M., İlçe, B. Y., Bouzid, A., Hamad, A. M., Murad, S., Elbarkouky, A. H., Sharif‐Askari, F. S., Bendardaf, R., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1737736
Iron-catalyzed oxidative stress reveals an exposome-related ferroptosis-resistant karyomegalic niche in BRCA1-linked renal carcinogenesis
Kong, Y., Shiraki, Y., Furuhashi, K., Maruyama, S., Imaoka, T., Enomoto, A., & Toyokuni, S. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104293
Deconvoluting the multi-faceted roles of alternative splicing events in cancer: From underlying mechanisms to innovative therapeutics
Hu, L., Wang, X., Fan, B., Zhao, Q., Zhong, Y., Lu, Y., Liao, M., Li, H., Fu, X., Wang, H., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.07.019
Synthesis and Characterization of Graphene/Cobalt Oxide (Co3O4)/Neodymium Oxide (Nd2O3) Nanoparticles and In Vitro Evaluation of Their Anticancer Activities
Mohammadian, E., Hashemi, S. M. H., Afshar, B. K., Memar, M., Shadboorestan, A., Nikoofal‐Sahlabadi, S., Naybandizadeh, S., & Omidi, M. (2026) · North Khorasan University of Medical Sciences · doi:10.66224/nkums.18.2.35
BRCA1/BRCA2 MUTATIONS IN BREAST CANCER: CLINICAL SIGNIFICANCE, PROGNOSTAIC VALUE, AND THERAPEUTIC IMPLICATIONS
Strzykała, A., Szlegiel, I., Gwiaździńska, O., Lewandowski, J., & Myszak, D. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5937
BindingDB Entry 3065: 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.
BindingDB (2009) · UC San Diego · doi:10.7270/q2bp014t
BindingDB Entry 50045840: Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination.
BindingDB (2016) · UC San Diego · doi:10.7270/q27s7qgb
BindingDB Entry 50017830: Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer.
BindingDB (2023) · UC San Diego · doi:10.7270/q2t72nj8
BindingDB Entry 50019492: A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives.
BindingDB (2024) · UC San Diego · doi:10.7270/q2gt5shc
BindingDB Entry 50031614: Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.
BindingDB (2010) · UC San Diego · doi:10.7270/q2dn457m
BindingDB Entry 50012065: Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers.
BindingDB (2022) · UC San Diego · doi:10.7270/q23x8b92
CNS Metastasis Patterns in BRCA1/2 Mutation Associated and Non-BRCA Associated Breast Cancers
Song, Y. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Genetic Modifiers of Risk of BRCA1- and BRCA2-Related Breast and Ovarian Cancers
Chenevix‐Trench, G., & Antoniou, A. C. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0477-5_6

Authors: Narod, S. A., & Foulkes, W. D.
Affiliations: Sunnybrook Health Science Centre (CA)
McGill University (CA)
Corresponding author: Narod, Steven A.
ORCID: Narod, Steven A.
Foulkes, William D.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-09
Volume: 4
Issue: 9
Pages: 665-676
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1431
OpenAlex: W2091961739
Cited by: 967
References: 187
Citations by year: 2026: 13 · 2025: 29 · 2024: 30 · 2023: 37 · 2022: 36 · 2021: 40 · 2020: 30 · 2019: 31 · 2018: 33 · 2017: 35 · 2016: 38 · 2015: 53 · 2014: 38 · 2013: 43 · 2012: 59
FWCI: 6.57
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords: BRCA1, BRCA2, hereditary breast cancer, genetic susceptibility, DNA repair, genetic epidemiology, breast cancer prevention, breast cancer treatment
MeSH terms: Breast Neoplasms, DNA Damage, DNA Repair, Female, Humans, Mutation, Molecular Epidemiology, Genes, BRCA1, Genetic Predisposition to Disease, Genes, BRCA2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

BRCA1 and BRCA2: 1994 and beyond

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks